Global Endometriosis Treatment Market Size, Share, Growth Analysis Report - Forecast 2034

Endometriosis Treatment Market: Industry Perspective

The global endometriosis treatment market size was worth around USD 1.65 Billion in 2024 and is predicted to grow to around USD 5.76 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 13.3% between 2025 and 2034.

The report analyzes the global endometriosis treatment market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the endometriosis treatment industry.

Request Free Sample

Endometriosis Treatment Market: Overview

Endometriosis is a medical condition that impacts the female segment of the population. Endometrial tissue typically acts as the lining for the uterus which is a female reproductive organ. In this condition, the tissue starts to grow outside of it leading to infertility or chronic pain. The industry refers to the various stakeholders that deal with condition diagnosis and treatment. It includes medicines and therapies involved to manage the symptoms of the condition. There are various types of drugs that are a part of the distribution system in the fraternity and include hormonal therapies like oral contraceptives and non-steroidal anti-inflammatory drugs (NSAIDs) along with certain surgical processes. These treatments are intended to provide pain relief or prevent the progression of the disease. The industry is registering higher growth due to multiple factors but is expected to witness challenges along the way.

Key Insights

• As per the analysis shared by our research analyst, the global endometriosis treatment market is estimated to grow annually at a CAGR of around 13.3% over the forecast period (2025-2034).
• Regarding revenue, the global endometriosis treatment market size was valued at around USD 1.65 Billion in 2024 and is projected to reach USD 5.76 Billion by 2034.
• The endometriosis treatment market is projected to grow at a significant rate due to increasing prevalence of endometriosis, rising awareness and early diagnosis, significant investments in research and development for novel therapies, and growing demand for effective pain management and fertility-preserving solutions.
• Based on Treatment Type, the Pain Medication segment is expected to lead the global market.
• On the basis of Drug Class, the NSAIDs segment is growing at a high rate and will continue to dominate the global market.
• Based on the Route Of Administration, the Oral segment is projected to swipe the largest market share.
• By Distribution Channel, the Hospital Pharmacy segment is expected to dominate the global market.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Request Free Sample

Endometriosis Treatment Market: Growth Drivers

Growing prevalence of the medical condition to drive market demand

The global endometriosis treatment market is projected to grow owing to the rising prevalence of the condition. The disease is extremely common and is known to impact 10% of the female population that has reached reproductive age. The condition is further impacted due to the non-availability of accurate diagnostic tools. Currently, the medical community does not have the answer to the exact cause of the condition making medicine development a tedious and completed task.

This has led to the piling of cases from multiple years in the past due to factors like lack of awareness, absence of sufficient treatment and diagnostic facilities, and general ignorance toward the condition. However, various government and non-government healthcare agencies have initiated mass campaigns to educate people about the condition and possible medication or therapies available at their disposal, leading to more patients coming out for seeking treatment. Changing the perception of the menstrual cycle and the medical problems associated with it has played a crucial role in the industry's growth in the last few years.

Endometriosis Treatment Market: Restraints

Absence of a cure to restrict the market growth

There are certain medical conditions that do not have any cure even in the advanced medical world. Endometriosis is one such condition since there is no permanent treatment for the condition. It can only be treated in terms of symptom management and delaying or stopping the progression of the disease if diagnosed at the right time. This acts as a severe drawback for the global endometriosis treatment market since women who do not have access to accurate information on the management of this condition, could continue to suffer from it or adopt local measures to curb the pain.

Endometriosis Treatment Market: Opportunities

Growing investment toward higher research to provide further opportunities

One of the key segments the endometriosis treatment industry size may improve is the growing investment toward higher research in the field of finding a cure for endometriosis. Some of these activities include a better understanding and application of hormonal therapies under which the medical professional aims at reducing the level of estrogen in the body. Currently, there is intensive research being conducted around aromatase inhibitors, selective progesterone receptor modulators, and gonadotropin-releasing hormone agonists and antagonists.

Endometriosis Treatment Market: Challenges

High cost associated with the treatment to challenge market growth

Endometriosis treatments are expensive. These procedures are carried out over a period of time and are unlike other treatment processes that require one time visit to the doctor. Furthermore, the outcome of the medical process varies from one patient to another and hence the endometriosis treatment industry players are unable to produce a standard medicine that works for all. In addition to this, hormonal therapies associated with the treatment can have severe side effects on the patients like headache, bone loss, hot flashes, and vaginal dryness. All of these factors work against global industry growth.

Endometriosis Treatment Market: Segmentation

The global endometriosis treatment market is segmented based on drug class, treatment type, route of administration, and region.

Based on drug class, the global market segments are oral contraceptives, NSAIDs, gonadotropin releasing hormones, and others. The industry witnessed the highest growth in the NSAIDs segment which dominated almost 19.51% of the segmental share. These medications are a sub-segment of the therapeutic drug class and they assist in decreasing fever & inflammation, and preventing any type of blood clots. The medicinal plan is highly effective in relieving any intensity of pain that is caused by endometriosis and it performs its role by releasing prostaglandins.

Based on treatment type, the endometriosis treatment industry is segmented into hormone therapy and pain medication.

By route of administration, the global market divisions are injectable, oral, and others. The highest growth was observed in the oral segment, which held more than 19.8% of the share. It is also expected to grow at the fastest CAGR during the forecast period. The high demand for the product is driven by the ease of consumption offered by these medicines. Oral contraceptives are the most prescribed medicines followed by injectables. The other segments include topical creams which may grow at a higher CAGR in the coming years due to ongoing research & development activities along with product innovation and rapid approvals.

In terms of Distribution Channel, the global endometriosis treatment market is categorized into Hospital Pharmacy, Retail Pharmacy, Others.

Endometriosis Treatment Market: Report Scope

Recent Developments:

• In March 2023, the research community at the University of Edinburgh announced that they are hopeful about the potential of the new treatment plan developed for treating endometriosis. The researchers will begin clinical trials soon which will involve around 100 women from London and Edinburgh. The new treatment method makes use of non-hormonal drugs and makes use of dichloroacetate
• In August 2022, the US Food and Drugs Administration (FDA) approved the use of MYFEMBREE®, developed by Pfizer and Myovant Sciences. The medicine can be used as a once-daily treatment to manage moderate to severe pain caused by the condition. The phase 3 SPIRIT program data showed positive results in reducing the associated pain
• In November 2022, The National Institute of Health and Care Excellence (NICE) announced that it will update its guidelines surrounding the diagnosis of Endometriosis. The existing guidelines also include subjects like surgical management when fertility is important and general-case surgical management

Endometriosis Treatment Market: Regional Analysis

North America to generate the highest revenue during the forecast period

The global endometriosis treatment market is projected to register the highest growth in North America. In 2022, the region dominated over 48.5% of the global market share. The growth may be driven due to the high prevalence rate of the condition along with wide-scale awareness about the various treatment plans and therapies available in the medical sector for treating the condition. Furthermore, the government of the US and Canada have undertaken multiple initiatives to promote understanding and awareness rate surrounding the condition.

In addition to this, the US is registering a high rate of FDA approvals for various new medicines and therapies which assists in improving the availability of the medication. Growth in Europe is anticipated to be led by growing demand for effective treatment of the condition along with rising research and development activities in the regional industry. The growth rate in Asia-Pacific is expected to be close to 18% during the forecast period.

Endometriosis Treatment Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the endometriosis treatment market on a global and regional basis.

The global endometriosis treatment market is dominated by players like:

• Bayer AG
• Pfizer Inc.
• AbbVie Inc.
• AstraZeneca
• ObsEva SA
• Teva Pharmaceutical Industries Ltd.
• Zydus Healthcare Limited
• Astellas Pharma Inc.
• Gedeon Richter Plc.
• Takeda Pharmaceutical Company Limited

The global endometriosis treatment market is segmented as follows;

By Treatment Type

• Pain Medication
• Hormone Therapy

By Drug Class

• NSAIDs
• Oral Contraceptive
• Gonadotropin Releasing Hormone
• Others

By Route Of Administration

• Oral
• Injectable
• Others

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America